Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Utilizing Benchmarking to Reduce Adverse Outcomes.

Chia MC, Yang AD.

Jt Comm J Qual Patient Saf. 2020 Apr;46(4):183-184. doi: 10.1016/j.jcjq.2020.02.007. No abstract available.

PMID:
32223904
2.

"The magic is in the mix": lessons from research capacity building in the Canadian tobacco control community, 2000-2010.

Riley BL, Viehbeck SM, Cohen JE, Chia MC.

Can J Public Health. 2013 Feb 25;104(2):e173-6.

3.

Efficacy of systemically administered mutant vesicular stomatitis virus (VSVDelta51) combined with radiation for nasopharyngeal carcinoma.

Alajez NM, Mocanu JD, Shi W, Chia MC, Breitbach CJ, Hui AB, Knowles S, Bell JC, Busson P, Takada K, Lo KW, O'Sullivan B, Gullane P, Liu FF.

Clin Cancer Res. 2008 Aug 1;14(15):4891-7. doi: 10.1158/1078-0432.CCR-07-4134.

4.

Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer.

Chia MC, Leung A, Krushel T, Alajez NM, Lo KW, Busson P, Klamut HJ, Bastianutto C, Liu FF.

Clin Cancer Res. 2008 Feb 15;14(4):984-94. doi: 10.1158/1078-0432.CCR-07-0828.

5.
6.

Combined in vivo bioluminescence and fluorescence imaging for cancer gene therapy.

Mocanu JD, Moriyama EH, Chia MC, Li JH, Yip KW, Huang DP, Bastianutto C, Wilson BC, Liu FF.

Mol Imaging. 2004 Oct;3(4):352-5.

PMID:
15802052
7.

Potential utility of BimS as a novel apoptotic therapeutic molecule.

Yip KW, Li A, Li JH, Shi W, Chia MC, Rashid SA, Mocanu JD, Louie AV, Sanchez O, Huang D, Busson P, Yeh WC, Gilbert R, O'sullivan B, Gullane P, Liu FF.

Mol Ther. 2004 Sep;10(3):533-44.

8.

A conditionally replicating adenovirus for nasopharyngeal carcinoma gene therapy.

Chia MC, Shi W, Li JH, Sanchez O, Strathdee CA, Huang D, Busson P, Klamut HJ, Liu FF.

Mol Ther. 2004 Jun;9(6):804-17.

9.

Redirecting tyrosine kinase signaling to an apoptotic caspase pathway through chimeric adaptor proteins.

Howard PL, Chia MC, Del Rizzo S, Liu FF, Pawson T.

Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11267-72. Epub 2003 Sep 17.

10.

Direct measure of insulin sensitivity with the hyperinsulinemic-euglycemic clamp and surrogate measures of insulin sensitivity with the oral glucose tolerance test: correlations with aberrant crypt foci promotion in rats.

Tran TT, Gupta N, Goh T, Naigamwalla D, Chia MC, Koohestani N, Mehrotra S, McKeown-Eyssen G, Giacca A, Bruce WR.

Cancer Epidemiol Biomarkers Prev. 2003 Jan;12(1):47-56.

11.

Adenovirus-p53 gene therapy in human nasopharyngeal carcinoma xenografts.

Lax SA, Chia MC, Busson P, Klamut HJ, Liu FF.

Radiother Oncol. 2001 Dec;61(3):309-12.

PMID:
11731001
12.

Cytotoxic dolabellane diterpenes from the Formosan soft coral Clavularia inflata.

Duh CY, Chia MC, Wang SK, Chen HJ, El-Gamal AA, Dai CF.

J Nat Prod. 2001 Aug;64(8):1028-31.

PMID:
11520220
13.

Polyethylene glycol 8000 and colon carcinogenesis: inhibition in the F344 rat, promotion in the Min mouse.

Naigamwalla D, Chia MC, Tran TT, Medline A, Hay K, Gallinger S, Bruce WR.

Cancer Res. 2000 Dec 15;60(24):6856-8.

14.

The role of adhesion molecules in atherosclerosis.

Chia MC.

Crit Rev Clin Lab Sci. 1998 Dec;35(6):573-602. Review.

PMID:
9885776
15.

Aberrant crypt focus promotion and glucose intolerance: correlation in the rat across diets differing in fat, n-3 fatty acids and energy.

Koohestani N, Chia MC, Pham NA, Tran TT, Minkin S, Wolever TM, Bruce WR.

Carcinogenesis. 1998 Sep;19(9):1679-84.

PMID:
9771941

Supplemental Content

Support Center